Mark Ayoub

Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis

Mark Ayoub, Harleen Chela, Nisar A. Amin et al. · Journal of Clinical Medicine · 2025 · 32 citations · Full text

The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study

Mark Ayoub, Carol Faris, Tajana Juranovic et al. · Cancers · 2024 · 28 citations · Full text

Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis

Mark Ayoub, Rafi Aibani, Tiana Dodd et al. · Cancers · 2024 · 10 citations · Full text